Inactive Instrument

News Oncologix Tech, Inc. Other OTC

Equities

OCLG

US68230M2098

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

DNAGO and Oncologix Tech, Inc. Announce Agreement for Business Combination to Create Publicly Listed Company Focused on Providing clinical genetic testing on all 20,000+ genes encompassing 7,000+ rare genetic diseases at affordable price	22-05-02	GL
DNAGO and Oncologix Tech, Inc. Announce Agreement for Business Combination to Create Publicly Listed Company Focused on Providing clinical genetic testing on all 20,000+ genes encompassing 7,000+ rare genetic diseases at affordable price	22-05-02	AQ
DNAGO.Ai entered into a definitive business combination agreement to acquire Oncologix Tech, Inc. in a reverse merger transaction.	22-05-01	CI
Oncologix Tech, Inc. Announces Management Changes	16-12-02	CI
Oncologix Tech, Inc. announced that it expects to receive $10 million in funding from Diversified Innovative Marketing Enterprises Limited	16-08-30	CI
Oncologix Tech, Inc. Announces Board Changes	16-06-24	CI
Oncologix Tech, Inc. Appoints Nikole Jessie as Director of Marketing and Public Relations	15-07-29	CI
Oncologix Tech Inc. Reports Revenue Results Third Quarter and Nine Months Ending May 31, 2015	15-07-21	CI
Oncologix Tech Eyes Acquisitions	15-07-21	CI
Oncologix Tech, Inc. Announces Earnings Results for the Second Quarter and Revenue Results for the Six Months Ended February 28, 2015; Provides Earnings Guidance for the Third Quarter and Full Year of Fiscal 2015	15-04-14	CI
Oncologix Seeks Acquisitions	15-04-14	CI
Oncologix Tech, Inc. Reports Earnings Results for the First Quarter Ending November 30, 2014; Provides Earnings Guidance for Second Quarter of 2015	15-01-16	CI
OCLG Mulls Acquisitions	14-12-30	CI
Oncologix Tech Mulls Acquisitions	14-10-07	CI
Oncologix Tech, Inc. acquired Esteemcare Inc. from Madhu Mathew Mammen and Imad Siddiqui for $0.5 million.	14-10-02	CI
Oncologix Tech, Inc. Announces Revenue Results for the Second Quarter and Half Year Ended February 28, 2014	14-04-21	CI
Oncologix Tech Inc. Closes $4,000,000 Revolving Credit Facility from Senior Lender	14-01-08	CI
Oncologix Tech, Inc. announced that it has received $0.04 million in funding.	13-08-07	CI
Oncologix Tech, Inc. acquired Angels of Mercy, Inc. from Clifford Haw and Jennifer Hebert for $0.65 million.	13-08-05	CI
Oncologix Tech, Inc. announced that it has received $0.1 million in funding	13-07-25	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Oncologix Tech, Inc. Other OTC

Equities

OCLG

US68230M2098

Summary

Filters